CMS Open Payments · Program Year 2024
EnableCV Inc.
EnableCV Inc. reported $11,588.59 across General Payments, Research, and Ownership to 73 physicians and teaching hospitals across 73 transactions.
- $11.6K
- All-tracks total
- 73
- Transactions
- 73
- Recipients
- #1621
- of 1,925 companies
EnableCV Inc. reported $11,588.59 across all CMS Open Payments tracks (General + Research + Ownership) to 73 physicians and teaching hospitals in Program Year 2024 - ranking #1621 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,588.59, averaging $158.75 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer enablecv-inc EnableCV Inc.
$11.6K · #1621/1,925 · 0.0% industry · PY2024
- TOT $11.6K
- RANK #1621
- SHARE 0.0%
- TXN 73
- RCP 73
- CAT 2
- GEN $11.6K
- TOP1 10.4%
- PY 2024
Volume peers
Nearest volume peer: Greiner Bio-One North America, Inc. ($11.6K)
EnableCV Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for EnableCV Inc.
Rank #1621 of 1,925 companies in CMS Open Payments for 2024 belongs to EnableCV Inc., which reported $11,588.59 across 73 transactions to 73 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $158.75 per transaction and $158.75 per recipient.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $6.3K, accounting for 53.9% of this company's General Payments and 54 transactions.
General Payment Breakdown by Type
Across 2 types of general payments, EnableCV Inc.'s largest category was "Food and Beverage" at $6.3K - 53.9% of General Payments.
How EnableCV Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $6.3K | 54 | 53.9% |
| Travel and Lodging | $5.3K | 19 | 46.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $4,587.03 (39.6%) of $11,588.59 in this company's General Payments records across 39 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for EnableCV Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Clifton Thomas Lewis
$1,199.52 across 3 reported transactions
- 2
Danny Ramzy
$994.59 across 5 reported transactions
- 3
Douglas a Murphy
$833.32 across 3 reported transactions
- 4
Yuji Kawano
$833.32 across 3 reported transactions
- 5
Husam Balkhy
$726.28 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as EnableCV Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about EnableCV Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with EnableCV Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Biobeat USA Inc.
Biolase MG LLC
Hoya Surgical Optics, Inc
Amnio Technology, LLC
Xenco Medical LLC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.